NDC 64038-620 - Cyclo/Mag 10mg/200mg
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 64038-620
- Package NDCs from labels
- 64038-620-03
- Manufacturer
- Living Well Pharmacy, Inc. | Apotheca Supply | Spectrum Laboratory Products, Inc.
- Effective date
- 2010-02-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CYCLO/MAG KIT | Living Well Pharmacy, Inc. | Apotheca Supply | Spectrum Laboratory Products, Inc. | 2010-02-17 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 64038-620-03 | Cyclo/Mag 10mg/200mg | 3 g in 1 BOTTLE | POWDER | 3 g | 1 g in 1g | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| CYCLOBENZAPRINE HYDROCHLORIDE | ACTIVE INGREDIENT | 0VE05JYS2P | CYCLO/MAG 10MG/200MG (CYCLOBENZAPRINE HYDROCHLORIDE, MAGNESIUM OXIDE) KIT [LIVING WELL PHARMACY, INC.] | 1 | |
| MAGNESIUM OXIDE | ACTIVE INGREDIENT | 3A3U0GI71G | CYCLO/MAG 10MG/200MG (CYCLOBENZAPRINE HYDROCHLORIDE, MAGNESIUM OXIDE) KIT [LIVING WELL PHARMACY, INC.] | 1 | |
| CYCLOBENZAPRINE | ACTIVE MOIETY | 69O5WQQ5TI | CYCLO/MAG 10MG/200MG (CYCLOBENZAPRINE HYDROCHLORIDE, MAGNESIUM OXIDE) KIT [LIVING WELL PHARMACY, INC.] | 1 | |
| MAGNESIUM OXIDE | ACTIVE MOIETY | 3A3U0GI71G | CYCLO/MAG 10MG/200MG (CYCLOBENZAPRINE HYDROCHLORIDE, MAGNESIUM OXIDE) KIT [LIVING WELL PHARMACY, INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | QPharma Inc | fbe6ba88-0581-50ef-e053-6394a90ab086 | 2025-12-02 | Warnings, Adverse reactions | 0VE05JYS2P |
| Cyclobenzaprine hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | A-S Medication Solutions | 6b06b11c-0546-4f6e-9509-ba612bbcb9fd | 2025-11-19 | Warnings, Adverse reactions | 0VE05JYS2P |
| Cyclobenzaprine hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | A-S Medication Solutions | f3187074-6b55-44a3-b969-40a808eb034a | 2025-11-19 | Warnings, Adverse reactions | 0VE05JYS2P |
| Cyclobenzaprine hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | A-S Medication Solutions | bf3c4c2e-b089-4f83-9c6a-7ca9d9abd3ba | 2025-11-19 | Warnings, Adverse reactions | 0VE05JYS2P |
| Cyclobenzaprine hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | A-S Medication Solutions | 1cb40f47-7fbb-4537-922d-04a08dd921c5 | 2025-11-19 | Warnings, Adverse reactions | 0VE05JYS2P |
| Cyclobenzaprine hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | PHOENIX RX LLC | 4383b26f-c39f-3d6a-e063-6294a90aba03 | 2025-11-13 | Warnings, Adverse reactions | 0VE05JYS2P |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Doc Rx | 4c054230-1978-44d2-9467-ed1994619113 | 2025-10-31 | Warnings, Adverse reactions | 0VE05JYS2P |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | AvPAK | 64f6d1be-4067-a5c7-2343-4aed651a0cac | 2025-10-28 | Warnings, Adverse reactions | 0VE05JYS2P |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE | AvPAK | e530fd1e-06fd-0432-e053-2995a90adf5f | 2025-10-28 | Warnings, Adverse reactions | 0VE05JYS2P |
| Magnesium Oxide | MAGNESIUM OXIDE | Kesin Pharma | 31f417f0-1637-eefa-e063-6294a90a121b | 2025-10-27 | Warnings | 3A3U0GI71G |
| Magnesium Oxide | MAGNESIUM OXIDE | Method Pharmaceuticals, LLC | 0af63651-f9d9-43b9-b6f0-4878466a82e6 | 2025-10-21 | Warnings | 3A3U0GI71G |
| Magnesium Oxide | MAGNESIUM OXIDE | A-S Medication Solutions | c14d2b4d-d6d8-4293-835e-5d893d5b7e6a | 2025-10-10 | Warnings | 3A3U0GI71G |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Bryant Ranch Prepack | 8a8c9479-b3ab-453a-bd8a-deaf38000742 | 2025-09-24 | Warnings, Adverse reactions | 0VE05JYS2P |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Bryant Ranch Prepack | cc93038f-1202-47f3-a959-2877877cc869 | 2025-09-11 | Warnings, Adverse reactions | 0VE05JYS2P |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Doc Rx | d4457b8c-fff8-4c19-8d5a-a667161e5446 | 2025-09-04 | Warnings, Adverse reactions | 0VE05JYS2P |
| CYCLOBENZAPRINE HYDROCHLORIDE | CYCLOBENZAPRINE HYDROCHLORIDE | A-S Medication Solutions | eb908b77-741c-473a-b2e9-4f82167c3088 | 2025-08-26 | Warnings, Adverse reactions | 0VE05JYS2P |
| CYCLOBENZAPRINE HYDROCHLORIDE | CYCLOBENZAPRINE HYDROCHLORIDE | A-S Medication Solutions | 4923ac1f-d463-465b-9e99-7312aef87861 | 2025-08-26 | Warnings, Adverse reactions | 0VE05JYS2P |
| CYCLOBENZAPRINE HYDROCHLORIDE | CYCLOBENZAPRINE HYDROCHLORIDE | A-S Medication Solutions | d6448bb1-9b8d-45f4-a14b-8328248e586e | 2025-08-26 | Warnings, Adverse reactions | 0VE05JYS2P |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Advanced Rx of Tennessee, LLC | 3bddfe25-00ba-747f-e063-6394a90a9ce6 | 2025-08-08 | Warnings, Adverse reactions | 0VE05JYS2P |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE | Aphena Pharma Solutions - Tennessee, LLC | 3bc7e2b4-e1a0-66e3-e063-6294a90a676a | 2025-08-07 | Warnings, Adverse reactions | 0VE05JYS2P |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.